Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Facilitators and Barriers to Eptinezumab Administration in Thailand: Real-World Experiences and Perspectives From Mixed-method Design and In-Depth Interviews (FACEpi)

NCT07035197 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT07035197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07035197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Facilitators and Barriers to Eptinezumab Administration in Thailand: Real-World Experiences and Perspectives From Mixed-method Design and In-Depth Interviews (FACEpi)
Lead sponsor
Chulalongkorn University
Phase
Observational
Overall status
Completed
Start date
August 25, 2025
Completion date
March 31, 2026
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, treatment, treatment refusal